Eclalbasaponin I exhibits significant anti-inflammatory and antioxidant properties, making it a compound of interest in pharmaceutical and cosmetic applications. It has been studied for its potential to inhibit pro-inflammatory cytokines and reduce oxidative stress in cellular models, suggesting utility in developing treatments for chronic inflammatory conditions such as arthritis and dermatitis. Its ability to modulate skin cell responses also supports its use in skincare formulations aimed at reducing redness, soothing irritation, and improving skin barrier function. Additionally, preliminary research indicates possible hepatoprotective effects, which may lead to applications in liver-protective therapies. Due to its natural origin and bioactivity, it is also explored as a lead compound in drug discovery for metabolic and degenerative diseases.